Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin Extended-release/simvastatin)
Links shared publicly online about this topic.
- 1,538total visits
Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin Extended-release/simvastatin)
Abbott (nyse: abt) has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. s
View full resource at medicalnewstoday.com
Tags: Cholesterol, Cholesterol Medication, Vitamin, Drug, FDA, Niaspan, Abbott Laboratories
Most Recently Shared on December 11, 2009 at 3:19 pm By:
MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin: http://bit.ly/4HlCmF Full http://bit.ly/7vMN53
Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin Extended-release/simvastatin)
medicalnewstoday.com — “Abbott has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. simcor is a fi” View full resource at medicalnewstoday.com
Most Recently Shared on December 12, 2009 at 12:22 pm By:
MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin: http://bit.ly/8fMHnz Full http://bit.ly/78Vmva
Advertisement
